VIJAYA NSE filing

Vijaya Diagnostic Acquires Arya Wellness Centre in Guwahati for ~₹46 Crore

The RealCase readHigh impact Positive

Vijaya Diagnostic Centre is acquiring Arya Wellness Centre in Guwahati for approximately ₹46 crore. The acquisition of the integrated diagnostic business is expected to be EPS accretive. Arya Wellness Centre reported ₹26 crore in revenue and ₹5.6 crore in EBITDA for FY26. The deal is anticipated to close by November/December 2026.

Why it matters

The acquisition represents a significant expansion into a new geographical region (North-East India) and strengthens the company's overall market presence and service offerings.

The market read

The acquisition is described as a strategic milestone, providing a strong platform for expansion and is expected to be EPS accretive, indicating a positive outlook.

Vijaya Diagnostic Centre Limited has announced the execution of a Business Transfer Agreement (BTA) for the 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam. This acquisition, valued at approximately ₹46 Crore, is structured as a slump sale and is expected to be EPS accretive from the outset.

Arya Wellness Centre, a leading B2C focused diagnostic center in Guwahati, was founded in 2021 as a joint venture. It offers advanced radiology and pathology services, with its business mix comprising 44% radiology and 56% pathology. The center reported a revenue from operations of ₹260 Million (₹26 crore) in FY26, with an EBITDA of ₹56 Million (₹5.6 crore) and PAT of ₹25 Million (₹2.5 crore).

The acquisition is strategically important for Vijaya Diagnostic Centre as it provides immediate access to an established operating platform in Guwahati, serving as a gateway to the wider North-East region. The company believes this move aligns with its philosophy of delivering high-quality diagnostics and patient experience. The transaction is expected to close by November/December 2026, subject to the satisfaction of conditions precedent.

Filing to action

What to do with a filing like this

Vijaya Diagnostic Centre Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Vijaya Diagnostic Centre Limited. Read the original for the full detail.

View original filing